Archivos de Bronconeumologia

Papers
(The H4-Index of Archivos de Bronconeumologia is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
The Relevance of REMAP-ILD for Ibero-American Countries: A Randomized Embedded Multifactorial Adaptive Platform (REMAP) Trial in the Field of Interstitial Lung Diseases (ILDs)129
Recall for Medications: The Fragile Balance Risk/Benefit110
Contents58
Cardiac Ultrasound Image Disappearance in the Precordial Area as a New Specific Ultrasound Sign for Diagnosing Neonatal Pneumothorax and Precardiac Thoracentesis Therapy: A Retrospective Case–Control 53
Diffuse Lung and Cardiac Involvement in Alveolar Echinococcus38
Out With the Old, in With the New: What Changes in the 9th Edition of the TNM Classification for Lung Cancer?35
Application of Extracorporeal Membrane Oxygenation Combined With High-flow Nasal Oxygen Therapy in Tracheal Stenosis Reconstructive Surgery: A Case Report34
Shared Vision, Common Future: The Power of Scientific Collaboration33
Histological Features and Gene Expression Profiling in Lung Transplantation From Donation After Circulatory Death30
Are Oxygen and Non-Invasive Ventilation Useful “Clean Doping Boosters” for Thoracoabdominal Asynchrony During Exertion in Severe COPD?30
Disseminated Tuberculosis30
Delayed Presentation of Traumatic Diaphragmatic Rupture With Hemothorax30
A Report on a Targeted Screening Population for Alpha-1-Antitrypsin Deficiency (AATD) in Central-Southern Italy29
Bullous Lung Disease Post-COVID29
Effect of Carbocysteine on Exacerbations and Lung Function in Patients With Mild-to-Moderate Chronic Obstructive Pulmonary Disease: A Multicentre, Double-Blind, Randomized, Placebo-Controlled Trial28
Bordetella bronchiseptica Pneumonia in an Immunocompetent Young Man28
Electronic Nicotine Delivery Systems: The New Threat27
Invasive Fungal Infections: No Trial, No Error, Just Uncertainty—Immunosuppression Diversifies, but Evidence Remains Anchored in Classical Models27
Real-world Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection Not Associated with Cystic Fibrosis: A Comparative Analysis From the INBREATHING Registry25
Changes in Non-invasive Ventilation Compliance in Patients With Amyotrophic Lateral Sclerosis: A Post-hoc Analysis25
Rethinking GOLD E: The Significance of a Single Moderate Exacerbation in COPD25
Early Failure, Late Failure, and Sustained Response to Biologics in Severe Asthma: A Long-term, Real-world, Multicentre study24
Nintedanib Combined With Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis: A Long-Term Retrospective Multicentre Study (Combi-PF)23
0.078570127487183